Angle PLC Announces Results for the Year Ended 31 December 2022
Preliminary Results for the year ended 31 December 2022FDA CLEARANCE A MAJOR BREAKTHROUGH FOR PARSORTIX LIQUID BIOPSParsortix system substantially out-performs standard of care for ovarian cancer diagnosisProstate